Insider Cluster (2 insiders) ·Filed May 28, 2026

EXEL

EXELIXIS, INC.
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $3.8M total
Actionable Insight • Neutral

Insider selling is routine in both dollar amount and seniority level. No bearish signal. Monitor the next earnings release for any guidance changes, but this cluster alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
EXEL ▲ +8.17% at T+60d
NEUTRAL call ✓ call won +8.17% · α vs SPY +7.24% · entry $50.32 → $54.43
Entry anchored
May 28, 03:59 PM ET
via exchange tick
T+1d
-0.08%
call -0.08% · α -0.35%
$50.28
settled 4mo ago
T+5d
+2.55%
call +2.55% · α +2.84%
$51.60
settled 4mo ago
T+20d
+8.85%
call +8.85% · α +12.48%
$54.77
settled 3mo ago
T+60d
+8.17%
call +8.17% · α +7.24%
$54.43
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Two EVPs at Exelixis sold a combined $3.79M in open-market sales over a week, with no insider buying. The sales are modest relative to the $12.9B market cap (~0.03%), and the cluster is driven by two senior commercial and R&D executives, not the CEO/CFO. Per the asymmetry rule, cluster sales are not amplified beyond the proportionality band, and the dollar amount is trivial for a company of this size.

Key Financial Metrics

Direction
selling
Total Value
$3.8M
Insiders
2

Key Facts

  • EVP Commercial Patrick J. Haley sold 32,100 shares at $49.81 for $1.60M on 2026-05-20.
  • EVP R&D Dana Aftab sold 43,451 shares at $50.35 for $2.19M on 2026-05-26.
  • Total insider sales: $3.79M, representing ~0.03% of Exelixis's $12.9B market cap.
  • No insider purchases occurred in the cluster window.
  • A director (David Edward Johnson) received a non-cash grant of 19,133 shares on 2026-05-27 with $0 economic value.
  • Prior 30-day insider activity included 4 sells totaling $5.9M, consistent with routine selling patterns.

Financial Impact

Total open-market sales of $3.79M, or ~0.03% of market cap — immaterial relative to company size.

insider selling volume

Risk Factors

  • No material risk identified from this insider activity.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
58% bullish (26 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-EXEL-1780086707364
12 reports for EXEL
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+60▲ +21.97%Feb 28, 2026
Filters
Rows
Reports for EXEL — sortable, filterable
TypeNow
Sep 11, 2026
21d ago
8-K
BEARISH ★ 6/10
$56.12 $58.36▼ −3.99%▼ −4.21%$58.40 (−4.06%)
Aug 10, 2026
7w ago
Press Release
BEARISH ★ 7/10
$51.33 $53.10▼ −3.44%▼ −3.85%$58.40 (−13.77%)
Jun 3, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$52.39 $53.50▲ +2.12%▲ +4.68%$58.40 (+11.48%)
May 29, 2026
17w ago
8-K
NEUTRAL ★ 3/10
$50.20 $52.70▲ +4.98%▲ +7.73%$58.40 (+16.34%)
May 28, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$50.32 $51.60▲ +2.55%▲ +2.84%$58.40 (+16.06%)
May 28, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$50.32 $51.60▲ +2.55%▲ +2.84%$58.40 (+16.06%)
May 28, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$50.32 $52.69▲ +4.71%▲ +7.23%$58.40 (+16.06%)
May 22, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$49.94 $48.49▼ −2.90%▼ −4.12%$58.40 (+16.95%)
May 19, 2026
19w ago
Insider Cluster
NEUTRAL ★ 3/10
$49.89 $51.46▲ +3.15%▲ +1.34%$58.40 (+17.06%)
May 7, 2026
21w ago
Insider Cluster
NEUTRAL ★ 2/10
$46.10 $51.29▲ +11.26%▲ +9.76%$58.40 (+26.69%)
Showing 10 of 12

US Market Status

Market Open — Closes in 3h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 29, 2026